Enteric-coated insulin microparticles delivered by lipopeptides of iturin and surfactin

References

• Akbari V, Hendijani F, Feizi A, et al. (2016). Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis. J Endocrinol Invest 39:215.
   PubMed Web of Science ®Google Scholar
• Arutchelvi J, Sangeetha J, Philip L, Doble M. (2014). Self-assembly of surfactin in aqueous solution: role of divalent counterions. Colloids Surf B Biointerfaces 116:396–402.
   PubMed Web of Science ®Google Scholar
• Bruce CD, Fegely KA, Rajabi-Siahboomi AR, McGinity JW. (2010). The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE. Eur J Pharm Biopharm 75:71–8.
   PubMed Web of Science ®Google Scholar
• Fonte P, Araújo F, Silva C, et al. (2015). Polymer-based nanoparticles for oral insulin delivery: Revisited approaches. Biotechnol Adv 33:1342–54.
   PubMed Web of Science ®Google Scholar
• García-Díaz M, Foged C, Nielsen HM. (2015). Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids. Int J Pharm 482:84–91.
   PubMed Web of Science ®Google Scholar
• Hashmat D, Shoaib MH, Mehmood ZA, et al. (2008). Development of enteric coated flurbiprofen tablets using opadry/acryleze system – a technical note. AAPS PharmSciTech 9:116–21.
   PubMed Web of Science ®Google Scholar
• Hwang YH, Kim MS, Song IB, et al. (2009). Subacute (28 day) toxicity of surfactin C, a lipopeptide produced by Bacillus subtilis, in rats. J Health Sci 55:351–5.
   Google Scholar
• Inès M, Dhouha G. (2015). Lipopeptide surfactants: production, recovery and pore forming capacity. Peptides 71:100–12.
   PubMed Web of Science ®Google Scholar
• Ismail R, Csóka I. (2017). Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs. Eur J Pharm Biopharm 115:257–67.
   PubMed Web of Science ®Google Scholar
• Joshi S, Bharucha C, Desai AJ. (2008). Production of biosurfactant and antifungal compound by fermented food isolate Bacillus subtilis 20B. Bioresour Technol 99:4603–8.
   PubMed Web of Science ®Google Scholar
• Kanzarkar M, Pathak PP, Vaidya M, et al. (2015). Oral insulin-delivery system for diabetes Mellitus. Pharm Pat Anal 4:29–36.
   PubMed Web of Science ®Google Scholar
• Li P, Tan A, Prestidge A, et al. (2014). Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm 477:390–8.
   PubMed Web of Science ®Google Scholar
• Li Q, Meng X, Wu X, et al. (2006). Purification of two antimicrobial substances produced by Bacillus subtilis strain B11 and their properties. Agric Sci China 5:363–9.
   Google Scholar
• Lim HP, Tey BT, Chan ES. (2014). Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin. J Control Release 186:11–21.
   PubMed Web of Science ®Google Scholar
• Lopes M, Simões S, Veiga F, et al. (2015). Why most oral insulin formulations do not reach clinical trials. Ther Deliv 6:973–87.
   PubMed Web of Science ®Google Scholar
• Ma G. (2015). Microencapsulation of protein drugs for drug delivery: Strategy, preparation, and applications. J Control Release 193:324–40.
   Web of Science ®Google Scholar
• Mansourpour M, Mahjub R, Amini M, et al. (2015). Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery. AAPS PharmSciTech 16:952–62.
   PubMed Web of Science ®Google Scholar
• Nur M, Vasiljevic T. (2017). Can natural polymers assist in delivering insulin orally? Int J Biol Macromol 103:889–901.
   PubMed Web of Science ®Google Scholar
• Otzen DE. (2017). Biosurfactants and surfactants interacting with membranes and proteins: Same but different?. Biochim Biophys Acta 1859:639–49.
   PubMed Web of Science ®Google Scholar
• Patel S, Ahmed S, Eswari JS. (2015). Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles. World J Microbiol Biotechnol 31:1177–93.
   PubMed Web of Science ®Google Scholar
• Sharma G, Sharma AR, Nam J, et al. (2015). Nanoparticle based insulin delivery system: the next generation efcient therapy for type 1 diabetes. J Nanobiotechnol 13:74.
   PubMed Web of Science ®Google Scholar
• Shen X, Yu D, Zhu L, et al. (2011). Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery. Int J Pharmaceu 408:200–7.
   PubMed Web of Science ®Google Scholar
• Sonia TA, Sharma CP. (2013). In vitro evaluation of quaternized polydimethylaminoethylmethacrylate sub-microspheres for oral insulin delivery. J Biomater Appl 28:62–73.
   PubMed Web of Science ®Google Scholar
• Sousa F, Castro P, Fonte P, Sarmento B. (2015). How to overcome the limitations of current insulin administration with new non-invasive delivery systems. Ther Deliv 6:83–94.
   PubMed Web of Science ®Google Scholar
• Wong CY, Martinez J, Dass CR. (2016). Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol 68:1093–108.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao Z, Zhao X, Qi G. (2016). A natural lipopeptide of surfactin for oral delivery of insulin. Drug Deliv 23:2084–93.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing X, Ding J, et al. (2017). Surfactin variants for intra-intestinal delivery of insulin. Eur J Pharm Biopharm 115:218–28.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shao D, Jiang C, et al. (2017). Biological activity of lipopeptides from Bacillus. Appl Microbiol Biotechnol 101:5951–60.
   PubMed Web of Science ®Google Scholar
• Zijlstra E, Heinemann L, Plum-Mörschel L. (2014). Oral insulin reloaded: a structured approach. J Diabetes Sci Technol 8:458–65.
   PubMedGoogle Scholar